Evidence map›Paper›PMID 33495627›Full record

ArticleNature protocols2021

Nuclei isolation of multiple brain cell types for omics interrogation.

Alexi Nott, Johannes C M Schlachetzki, Bethany R Fixsen, Christopher K Glass

Open access · greenAbstract read
In one paragraph

Article in Nature protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Alexi Nott *Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA. a.nott@imperial.ac.uk.ORCID http://orcid.org/0000-0002-2029-7193
Johannes C M Schlachetzki *Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA. jschlachetzki@health.ucsd.edu.ORCID http://orcid.org/0000-0002-7801-9743
Bethany R FixsenDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Christopher K GlassDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA. ckg@ucsd.edu.ORCID http://orcid.org/0000-0003-4344-3592
University of California San Diego · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAVID J MOORE · 2001 to 2026
$50.4M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JAMES B BREWER · 2019 to 2026
$34.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007198 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHI, NEIL C, INSEL, PAUL A · 1985 to 2024
$29.3M
UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
The Enhancer Code of AD-A Genetic ApproachR01AG056511 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLASS, CHRISTOPHER K, ROSENFELD, MICHAEL G · 2018 to 2022
$5.3M
Interdisciplinary Research Fellowship in NeuroAIDSR25MH081482 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARIANA CHERNER · 2007 to 2026
$5.2M
Mechanisms controlling human microglia gene expressionR01NS096170 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLASS, CHRISTOPHER K · 2016 to 2025
$4.3M
Defining the cell-specific epigenetic landscape leading to altered gene expression signatures in HIV-Associated Neurocognitive DisorderRF1AG061060 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLASS, CHRISTOPHER K · 2018 to 2018
$2.7M
Decoding Alzheimer's disease-related enhancers in microgliaF30AG062159 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIXSEN, BETHANY ROSE · 2018 to 2021
$162k
Medical Research CouncilNCATS NIH HHS KL2 TR001444NIA NIH HHS F30 AG062159NIA NIH HHS P30 AG062429NIA NIH HHS R01 AG056511NIA NIH HHS RF1 AG061060NIGMS NIH HHS T32 GM007198NIMH NIH HHS P30 MH062512NIMH NIH HHS R25 MH081482NINDS NIH HHS R01 NS096170
6 · The paper itself

Abstract

We present a nuclei isolation protocol for genomic and epigenomic interrogation of multiple cell type populations in the human and rodent brain. The nuclei isolation protocol allows cell type-specific profiling of neurons, microglia, oligodendrocytes, and astrocytes, being compatible with fresh and frozen samples obtained from either resected or postmortem brain tissue. This 2-day procedure consists of tissue homogenization with fixation, nuclei extraction, and antibody staining followed by fluorescence-activated nuclei sorting (FANS) and does not require specialized skillsets. Cell type-specific nuclei populations can be used for downstream omic-scale sequencing applications with an emphasis on epigenomic interrogation such as histone modifications, transcription factor binding, chromatin accessibility, and chromosome architecture. The nuclei isolation protocol enables translational examination of archived healthy and diseased brain specimens through utilization of existing medical biorepositories.

Indexed as

AnimalsAstrocytesBrainBrain ChemistryCell NucleusChromatinEpigenomicsFlow CytometryGenomicsHumansNeuronsProtein Processing, Post-TranslationalChromatin

Identifiers

PMID33495627
PMCPMC7969463
OpenAlexW3124325910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.